“Latest Stem Cells News”

The adult stem cell nutrition is the world’s first natural stem cell enhancer, supports the natural release of adult stem cells which, Rebuild, Renew, Rejuvenate the Body!

Numerous studies performed by various scientific teams throughout the world, including the National Institute of Health have clearly established that the higher the levels of circulating stem cells the better the ability of the body to maintain optimal health.

A recent publication in the New England Journal of Medicine reported that the level of stem cells in the blood was one of the best indicators of cardiovascular health. Elevating the number of stem cells in the blood has been shown to improve health in many ways. This stem cell nutrition supports the natural release of stem cells by 25-30%, which is bound to assist the body in maintaining optimal health.

A new drug combination tested in mice may target the cells responsible for driving some pancreatic tumors. The combination of gemcitabine and the experimental drug tigatuzumab eliminated populations of cancer stem cells and reduced tumor growth in a mouse model of pancreatic cancer, researchers from the Johns Hopkins Sidney Kimmel Cancer Center reported at the AACR annual meeting.

The results provide a rationale for testing the promising combination in patients with this deadly disease, Dr. Rajesh Kumar NV and his colleagues concluded.

Cancer stem cells are thought to self renew while giving rise to tumors, and they may resist conventional treatments. The researchers found that human pancreatic cancer stem cells overexpress a protein called death receptor-5 (DR-5), which is involved in programmed cell death (apoptosis). The protein is also the target of tigatuzumab, a humanized monoclonal antibody also known as CS-1008.

To evaluate the drug’s effects on these important cells, mice were given tigatuzumab alone, gemcitabine alone, or a combination. Although gemcitabine reduced tumor size, it increased levels of pancreatic cancer stem cells (as defined by the protein markers ALDH, CD24, and CD44), and all of the tumors recurred. The combination treatment, however, led to long-term remissions in half of the treated mice.

Stem Cell Research Press Release

I released this press release on the Real Cost of Embryonic Stem Cell Research earlier this week and I just wanted to make sure you all saw it- the title was this:
Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research

RSCI’s Chairman expressed his concern that since few people can afford to travel outside the country for medical treatments, America needs to put more focus on approving ultra safe adult stem cell treatments to alleviate the suffering of millions diagnosed with so-called untreatable diseases.

Don Margolis, founder of the world’s first stem cell treatment company and chairman of the Repair Stem Cell Institute, today issued a statement which took strong exception to Washington’s emphasis on embryonic stem cells over both Repair (Adult) Stem Cells and induced Pluripotent stem cells (iPS).

Margolis said, “This leads to one key question which no one in America seems to ask: Why is the FDA, which indiscriminately rushes unproven deadly drugs to AIDS patients, forbidding six million dying heart patients access to long-proven SAFE stem cell therapy?” Is it because heart patients don’t count in politics while AIDS patients do? Or is there another reason why they allow drugs such as Vioxx and forbid risk-free stem cells?